NCT00969072View on ClinicalTrials.gov

Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Benign Prostatic HyperplasiaProstatic Hyperplasia
Interventions
DRUG

GI198745 0.05mg

GI198745 (drug) - benign prostatic hyperplasia

DRUG

GI198745 0.5mg

GI198745 (drug) - benign prostatic hyperplasia

DRUG

GI198745 2.5mg

GI198745 (drug) - benign prostatic hyperplasia

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY